Sun Pharma to raise Rs 10,000 crore to part-finance Organon deal

Sun Pharma is set to raise ₹10,000 crore to part-finance its deal involving Organon. The proposed fundraising will be divided into two tranches with different coupon rates.

Two tranches set out

The larger tranche will total ₹7,000 crore and carry a coupon of 8.20%. A second tranche of ₹3,000 crore will carry a coupon of 8.05%.

The ₹3,000 crore tranche also includes a put option in 2028. The financing structure therefore combines two fundraising portions with separate pricing terms and a specific option attached to the smaller tranche.

Why the fundraising matters

The planned ₹10,000 crore raise is directly linked to Sun Pharma’s Organon transaction, providing part of the funding for the deal. The size of the proposed financing makes its terms relevant to the overall transaction structure.

Based on the available details, the company has disclosed the amount of the raise, the coupon rates for both tranches and the 2028 put option attached to the ₹3,000 crore portion. No further information on the transaction or the fundraising has been provided.

Outlook

Sun Pharma’s next financing steps will determine how the proposed two-tranche raise is implemented. For now, the key features are the ₹10,000 crore total, the 8.20% and 8.05% coupons, and the 2028 put option on the smaller tranche.